Evaluation of CoronaVac and CoviShield Vaccines on SARS-CoV-2 Infection in Healthcare Workers in Salvador, Brazil

The emergence and rapid spread of the SARS-CoV-2 Gamma variant in Brazil have raised concerns about SARS-CoV-2 vaccines’ neutralizing capacity and viral load impact. Our study aimed to assess the influence of the CoviShield and CoronaVac vaccines on the Ct-N2 value in the healthcare organization’s s...

Full description

Bibliographic Details
Main Authors: Jesús Enrique Patiño Escarcina, Felipe de Jesus Souza, Ana Keila Carvalho Vieira Da Silva, Keile Kemyly Assis Da Silva, Ruan Barbosa Souza, Saulo Reis Nery Santos, Eduardo M. Netto
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:COVID
Subjects:
Online Access:https://www.mdpi.com/2673-8112/3/11/112
_version_ 1797459659703975936
author Jesús Enrique Patiño Escarcina
Felipe de Jesus Souza
Ana Keila Carvalho Vieira Da Silva
Keile Kemyly Assis Da Silva
Ruan Barbosa Souza
Saulo Reis Nery Santos
Eduardo M. Netto
author_facet Jesús Enrique Patiño Escarcina
Felipe de Jesus Souza
Ana Keila Carvalho Vieira Da Silva
Keile Kemyly Assis Da Silva
Ruan Barbosa Souza
Saulo Reis Nery Santos
Eduardo M. Netto
author_sort Jesús Enrique Patiño Escarcina
collection DOAJ
description The emergence and rapid spread of the SARS-CoV-2 Gamma variant in Brazil have raised concerns about SARS-CoV-2 vaccines’ neutralizing capacity and viral load impact. Our study aimed to assess the influence of the CoviShield and CoronaVac vaccines on the Ct-N2 value in the healthcare organization’s staff who experienced primary SARS-CoV-2 infection. We examined sixty-three COVID-19 cases reported in the first half of 2021 and identified similar clinical and laboratory characteristics among individuals, regardless of the vaccine they received. Surprisingly, our observations revealed that both CoviShield and CoronaVac vaccines had no impact on viral load or the development and severity of symptoms. These findings suggest a potential reduction in neutralizing response and indicate the need to consider the incorporation of other SARS-CoV-2 vaccines and maintain additional containment measures against SARS-CoV-2, as they remain imperative despite vaccination efforts.
first_indexed 2024-03-09T16:54:35Z
format Article
id doaj.art-44a9b7ccb44b4142aa05d3c1d0aaaf77
institution Directory Open Access Journal
issn 2673-8112
language English
last_indexed 2024-03-09T16:54:35Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series COVID
spelling doaj.art-44a9b7ccb44b4142aa05d3c1d0aaaf772023-11-24T14:36:33ZengMDPI AGCOVID2673-81122023-10-013111639164710.3390/covid3110112Evaluation of CoronaVac and CoviShield Vaccines on SARS-CoV-2 Infection in Healthcare Workers in Salvador, BrazilJesús Enrique Patiño Escarcina0Felipe de Jesus Souza1Ana Keila Carvalho Vieira Da Silva2Keile Kemyly Assis Da Silva3Ruan Barbosa Souza4Saulo Reis Nery Santos5Eduardo M. Netto6José Silveira Foundation, Center for Research, Learning and Innovation, Salvador 40210-320, BA, BrazilJosé Silveira Foundation, Center for Research, Learning and Innovation, Salvador 40210-320, BA, BrazilJosé Silveira Foundation, Center for Research, Learning and Innovation, Salvador 40210-320, BA, BrazilJosé Silveira Foundation, Center for Research, Learning and Innovation, Salvador 40210-320, BA, BrazilJosé Silveira Foundation, Center for Research, Learning and Innovation, Salvador 40210-320, BA, BrazilJosé Silveira Foundation, Center for Research, Learning and Innovation, Salvador 40210-320, BA, BrazilJosé Silveira Foundation, Center for Research, Learning and Innovation, Salvador 40210-320, BA, BrazilThe emergence and rapid spread of the SARS-CoV-2 Gamma variant in Brazil have raised concerns about SARS-CoV-2 vaccines’ neutralizing capacity and viral load impact. Our study aimed to assess the influence of the CoviShield and CoronaVac vaccines on the Ct-N2 value in the healthcare organization’s staff who experienced primary SARS-CoV-2 infection. We examined sixty-three COVID-19 cases reported in the first half of 2021 and identified similar clinical and laboratory characteristics among individuals, regardless of the vaccine they received. Surprisingly, our observations revealed that both CoviShield and CoronaVac vaccines had no impact on viral load or the development and severity of symptoms. These findings suggest a potential reduction in neutralizing response and indicate the need to consider the incorporation of other SARS-CoV-2 vaccines and maintain additional containment measures against SARS-CoV-2, as they remain imperative despite vaccination efforts.https://www.mdpi.com/2673-8112/3/11/112viral loadSARS-CoV-2vaccines
spellingShingle Jesús Enrique Patiño Escarcina
Felipe de Jesus Souza
Ana Keila Carvalho Vieira Da Silva
Keile Kemyly Assis Da Silva
Ruan Barbosa Souza
Saulo Reis Nery Santos
Eduardo M. Netto
Evaluation of CoronaVac and CoviShield Vaccines on SARS-CoV-2 Infection in Healthcare Workers in Salvador, Brazil
COVID
viral load
SARS-CoV-2
vaccines
title Evaluation of CoronaVac and CoviShield Vaccines on SARS-CoV-2 Infection in Healthcare Workers in Salvador, Brazil
title_full Evaluation of CoronaVac and CoviShield Vaccines on SARS-CoV-2 Infection in Healthcare Workers in Salvador, Brazil
title_fullStr Evaluation of CoronaVac and CoviShield Vaccines on SARS-CoV-2 Infection in Healthcare Workers in Salvador, Brazil
title_full_unstemmed Evaluation of CoronaVac and CoviShield Vaccines on SARS-CoV-2 Infection in Healthcare Workers in Salvador, Brazil
title_short Evaluation of CoronaVac and CoviShield Vaccines on SARS-CoV-2 Infection in Healthcare Workers in Salvador, Brazil
title_sort evaluation of coronavac and covishield vaccines on sars cov 2 infection in healthcare workers in salvador brazil
topic viral load
SARS-CoV-2
vaccines
url https://www.mdpi.com/2673-8112/3/11/112
work_keys_str_mv AT jesusenriquepatinoescarcina evaluationofcoronavacandcovishieldvaccinesonsarscov2infectioninhealthcareworkersinsalvadorbrazil
AT felipedejesussouza evaluationofcoronavacandcovishieldvaccinesonsarscov2infectioninhealthcareworkersinsalvadorbrazil
AT anakeilacarvalhovieiradasilva evaluationofcoronavacandcovishieldvaccinesonsarscov2infectioninhealthcareworkersinsalvadorbrazil
AT keilekemylyassisdasilva evaluationofcoronavacandcovishieldvaccinesonsarscov2infectioninhealthcareworkersinsalvadorbrazil
AT ruanbarbosasouza evaluationofcoronavacandcovishieldvaccinesonsarscov2infectioninhealthcareworkersinsalvadorbrazil
AT sauloreisnerysantos evaluationofcoronavacandcovishieldvaccinesonsarscov2infectioninhealthcareworkersinsalvadorbrazil
AT eduardomnetto evaluationofcoronavacandcovishieldvaccinesonsarscov2infectioninhealthcareworkersinsalvadorbrazil